These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24180402)

  • 41. Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus.
    Rollan A; Arab JP; Camargo MC; Candia R; Harris P; Ferreccio C; Rabkin CS; Gana JC; Cortés P; Herrero R; Durán L; García A; Toledo C; Espino A; Lustig N; Sarfatis A; Figueroa C; Torres J; Riquelme A
    World J Gastroenterol; 2014 Aug; 20(31):10969-83. PubMed ID: 25152601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies].
    Bigard MA
    Presse Med; 2001 Sep; 30(26):1305-12. PubMed ID: 11603094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer.
    Choi IJ
    Korean J Intern Med; 2013 Sep; 28(5):525-37. PubMed ID: 24009446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
    Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G;
    Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
    Hu FL; Jia JC; Li YL; Yang GB
    J Int Med Res; 2003; 31(6):469-74. PubMed ID: 14708410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular approaches and modern clinical strategies for the management of Helicobacter pylori infection in Japan.
    Suzuki H; Nishizawa T; Tsugawa H; Hibi T
    Keio J Med; 2012; 61(4):109-19. PubMed ID: 23324305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [New S3 guideline of DGVS for eradication of Helicobacter pylori--recommendations for routine general practice. Focus on the stomach bacterium].
    MMW Fortschr Med; 2009 May; 151(22):48-9. PubMed ID: 19526970
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of Helicobacter pylori infection after gastric surgery.
    Lin YS; Chen MJ; Shih SC; Bair MJ; Fang CJ; Wang HY
    World J Gastroenterol; 2014 May; 20(18):5274-82. PubMed ID: 24833857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
    Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
    Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
    Malfertheiner P; Megraud F; O'Morain CA; Gisbert JP; Kuipers EJ; Axon AT; Bazzoli F; Gasbarrini A; Atherton J; Graham DY; Hunt R; Moayyedi P; Rokkas T; Rugge M; Selgrad M; Suerbaum S; Sugano K; El-Omar EM;
    Gut; 2017 Jan; 66(1):6-30. PubMed ID: 27707777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of Antibiotic-Resistant
    Khien VV; Thang DM; Hai TM; Duat NQ; Khanh PH; Ha DT; Binh TT; Dung HDQ; Trang TTH; Yamaoka Y
    Gut Liver; 2019 Sep; 13(5):483-497. PubMed ID: 31009957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
    Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.
    Miftahussurur M; Yamaoka Y
    Molecules; 2015 Apr; 20(4):6068-92. PubMed ID: 25856059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Bismuth in the Eradication of Helicobacter pylori.
    Alkim H; Koksal AR; Boga S; Sen I; Alkim C
    Am J Ther; 2017; 24(6):e751-e757. PubMed ID: 26808355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of
    Suzuki S; Esaki M; Kusano C; Ikehara H; Gotoda T
    World J Gastroenterol; 2019 Apr; 25(16):1907-1912. PubMed ID: 31086459
    [No Abstract]   [Full Text] [Related]  

  • 58. Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.
    Zhang S; Lee DS; Morrissey R; Aponte-Pieras JR; Rogers AB; Moss SF
    Cancer Lett; 2014 Dec; 355(1):106-12. PubMed ID: 25218349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.
    Park CS; Lee SM; Park CH; Koh HR; Jun CH; Park SY; Lee WS; Joo YE; Kim HS; Choi SK; Rew JS
    Am J Gastroenterol; 2014 Oct; 109(10):1595-602. PubMed ID: 25091062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.
    Tepes B; Brglez Jurecic N; Tepes K; Espada Sanchez M; Perez Nyssen O; O'Morain C; Mégraud F; Gisbert J
    Dig Dis; 2021; 39(4):318-324. PubMed ID: 33099549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.